Xadago and Hallucination, visual - a phase IV clinical study of FDA data

Summary:

Hallucination, visual is reported as a side effect among people who take Xadago (safinamide mesylate), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Aspirin, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Hallucination, visual when taking Xadago. It is created by eHealthMe based on reports of 1,020 people who have side effects when taking Xadago from the FDA, and is updated regularly.

What is Xadago?

Xadago has active ingredients of safinamide mesylate. eHealthMe is studying from 1,022 Xadago users. Check the latest studies of Xadago.

What is Hallucination, visual?

Hallucination, visual (seeing things that aren't there) is found to be associated with 1,055 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Hallucination, visual.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

1,020 people reported to have side effects when taking Xadago.
Among them, 24 people (2.35%) have Hallucination, visual.

Could Xadago cause Hallucination, visual?

Among these 24 people:

How long have people been on Xadago when they have Hallucination, visual? *

What is the gender of people who have Hallucination, visual when taking Xadago? *

female: 79.17 %
male: 20.83 %

What is the age of people who have Hallucination, visual when taking Xadago? *

What are other drugs people take besides Xadago? *

Aspirin: 5 people, 20.83%
Pregabalin: 4 people, 16.67%
Simvastatin: 4 people, 16.67%
Nuplazid: 4 people, 16.67%
Sinemet: 3 people, 12.50%
Rytary: 3 people, 12.50%
Rivastigmine: 3 people, 12.50%
Sertraline: 2 people, 8.33%
Lisinopril: 2 people, 8.33%
Amantadine Hydrochloride: 2 people, 8.33%

What are other side effects people have besides Hallucination, visual? *

Fall: 13 people, 54.17%
Dyskinesia (abnormality or impairment of voluntary movement): 10 people, 41.67%
Drowsiness: 2 people, 8.33%
Sleep Disorder: 2 people, 8.33%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 8.33%
Gait Disturbance: 2 people, 8.33%
Freezing Phenomenon: 2 people, 8.33%
Fatigue (feeling of tiredness): 2 people, 8.33%
Dementia (madness): 2 people, 8.33%
High Blood Pressure: 2 people, 8.33%

What are the existing conditions these people have? *

Parkinson's Disease: 21 people, 87.50%
Neuralgia (pain in one or more nerves): 8 people, 33.33%
High Blood Cholesterol: 6 people, 25.00%
Platelet Aggregation Inhibition: 5 people, 20.83%
Depression: 5 people, 20.83%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 8.33%
Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 8.33%
Delusion (a false belief or opinion): 2 people, 8.33%
Urinary Tract Infection: 1 person, 4.17%
Sleep Disorder: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Xadago and have Hallucination, visual?

- Check whether Hallucination, visual is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xadago:

Xadago (1,022 reports)

Browse all side effects of Xadago:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucination, visual:

Hallucination, visual (1,055 drugs)

Browse all the conditions that are associated with Hallucination, visual:

Hallucination, visual (1,370 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on safinamide mesylate (the active ingredients of Xadago) and Xadago (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.